In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains
- PMID: 224964
In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains
Abstract
Lymphocytes from 38 human cord blood and 9 adult circulating blood were aliquoted and infected in parallel either with the B95-8 EBV strain (produced by cotton-top marmoset lymphocytes transformed by EBV originating from an infectious mononucleosis line) or with the M81 EB virus (produced by callithrix jacchus marmoset lymphocytes transformed by EBV originating from a nasopharyngeal carcinoma (NPC) derived line). Significant differences were observed in the lymphoblastoid lines obtained and involved cell morphology, cell growth and synthesis of viral antigen. Cord blood lymphocytes infected with M81 virus resulted in lymphoblastoid lines where EA and VCA synthesis and production of virions took place, whereas this was not observed in B95-8 induced lines.
Similar articles
-
In vitro transforming activity of EBV. I-Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes.Biomedicine. 1976 Dec 5;25(9):349-52. Biomedicine. 1976. PMID: 187263
-
The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.Oncogene. 1995 Nov 2;11(9):1711-9. Oncogene. 1995. PMID: 7478598
-
Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT).J Natl Cancer Inst. 1985 Jan;74(1):57-60. J Natl Cancer Inst. 1985. PMID: 2982054
-
Phosphonoacetic acid: inhibition of transformation of human cord blood lymphocytes by Epstein-Barr virus.Cancer Biochem Biophys. 1979;3(4):157-62. Cancer Biochem Biophys. 1979. PMID: 233303
-
Differences in expression of surface marker characteristics on Epstein-Barr virus-transformed human and simian lymphoid cell lines.Primates Med. 1978;10:149-55. Primates Med. 1978. PMID: 205852
Cited by
-
Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.J Virol. 2018 Feb 26;92(6):e01794-17. doi: 10.1128/JVI.01794-17. Print 2018 Mar 15. J Virol. 2018. PMID: 29263273 Free PMC article.
-
Common Marmoset Cell Lines and Their Applications in Biomedical Research.Cells. 2023 Aug 8;12(16):2020. doi: 10.3390/cells12162020. Cells. 2023. PMID: 37626830 Free PMC article. Review.
-
A Polymorphism in the Epstein-Barr Virus EBER2 Noncoding RNA Drives In Vivo Expansion of Latently Infected B Cells.mBio. 2022 Jun 28;13(3):e0083622. doi: 10.1128/mbio.00836-22. Epub 2022 Jun 1. mBio. 2022. PMID: 35642944 Free PMC article.
-
Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11.Antimicrob Agents Chemother. 2010 Jun;54(6):2338-44. doi: 10.1128/AAC.01142-09. Epub 2010 Mar 22. Antimicrob Agents Chemother. 2010. PMID: 20308370 Free PMC article.
-
Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient.J Virol. 2005 Dec;79(24):15323-30. doi: 10.1128/JVI.79.24.15323-15330.2005. J Virol. 2005. PMID: 16306603 Free PMC article.